© 2008 BionorImmuno, Inc. All rights Reserved
contact sitemap careers events news research investors pipeline about us homeHCV
P2
P1
HIV
Read more
Read more
Influenza
OTHER INDICATIONS
Cervical Cancer (HPV)
Read more
Read more
Vacc-C5
Vacc-5q
Vacc-4x
P3
CLINICAL STUDIES
RESEARCH/ PRE-CLINICAL
Read more
PIPELINE
Read more
Bionor Immuno AS is a multidisciplinary biomedical drug development company with a well-established platform technology for the development of therapeutic and preventative vaccines for infectious diseases using a modified peptide-based approach.
INVESTORS NEWS SITEMAP CONTACT US EVENTS CAREERS RESEARCH PIPELINE ABOUT USBionor Immuno AS, a subsidary of Bionor Pharma ASA was established on July 14th 2000 as a spin off from the R&D on immune based therapies that until then had been performed by its sister company, Bionor AS. Both companies are located at the Telemark Biomedical Centre, Skien, Norway together with two of its development partners AS Telelab and Mericon AS.
HOME